$4.46 -0.2 -3.7%
Last Trade - 9:00pm
| Market Cap | ÂŁ99.1m |
| Enterprise Value | ÂŁ76.9m |
| Revenue | ÂŁn/a |
| Position in Universe | 4761st / 6713 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Dec | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 1.34 | 3.99 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
BioSig Technologies, Inc. is a commercial-stage medical device company. The Company is commercializing biomedical signal processing technology platform to extract information from physiologic signals. The Company focuses on providing intracardiac signal information to electrophysiologists during electrophysiology (EP) studies and cardiac catheter ablation procedures for atrial fibrillation (AF) and ventricular tachycardia (VT). The Company is engaged in developing the Precise Uninterrupted Real-time evaluation of Electrograms (PURE) electro-pneumatic (EP) System, a surface electrocardiogram and intracardiac multichannel recording and analysis system that acquires, processes and displays electrocardiogram and electrograms required during electrophysiology studies and ablation procedures. The PURE EP System is a signal acquisition and processing technology.
| Last Annual | December 31st, 2019 |
| Last Interim | September 30th, 2020 |
| Incorporated | April 21, 2011 |
| Public Since | September 22, 2014 |
| No. of Shareholders: | 332 |
| No. of Employees: | 33 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | Nasdaq Composite , |
| Exchange | NASDAQ Capital Market |
| Shares in Issue | 30,248,713 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | 54 WILTON ROAD 2ND FLOOR, WESTPORT, 06880, United States |
| Web | https://biosigtech.com/ |
| Phone | +1 203 4095444 |
| Contact | () |
| Auditors | Liggett & Webb P.A |
As of 9:00pm, shares in Biosig Technologies Inc are trading at $4.46, giving the company a market capitalisation of ÂŁ99.1m. This share price information is delayed by 15 minutes.
Shares in Biosig Technologies Inc are currently trading at $4.46 and the price has moved by 15.75% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biosig Technologies Inc price has moved by -7.06% over the past year.
Of the analysts with advisory recommendations for Biosig Technologies Inc, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Biosig Technologies Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Biosig Technologies Inc is scheduled to issue upcoming financial results on the following dates:
Biosig Technologies Inc does not currently pay a dividend.
Biosig Technologies Inc does not currently pay a dividend.
Biosig Technologies Inc does not currently pay a dividend.
To buy shares in Biosig Technologies Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Biosig Technologies Inc are currently trading at $4.46, giving the company a market capitalisation of ÂŁ99.1m.
Here are the trading details for Biosig Technologies Inc:
Based on an overall assessment of its quality, value and momentum, Biosig Technologies Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Biosig Technologies Inc are currently priced at $4.46. At that level they are trading at 0.181% discount to the analyst consensus target price of 0.00.
Analysts covering Biosig Technologies Inc currently have a consensus Earnings Per Share (EPS) forecast of -2.21 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biosig Technologies Inc. Over the past six months, the relative strength of its shares against the market has been -44.25%. At the current price of $4.46, shares in Biosig Technologies Inc are trading at -28.5% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Biosig Technologies Inc.
Biosig Technologies Inc's management team is headed by:
Here are the top five shareholders of Biosig Technologies Inc based on the size of their shareholding:
